Challenger rejects Daiichi Life’s revised takeover offer for the Australian insurer, saying the new proposal still falls short of what it would consider acceptable. Bloomberg reports the bid is for about A$6.5 billion (US$4.4 billion), and describes the decision as the second rejection within roughly a month.

Channel NewsAsia similarly frames the move as a failure of the revised offer to meet Challenger’s expectations, noting that Challenger’s position has not changed despite the updated terms. Together, the accounts present a continued standoff between the companies, with Challenger’s share price falling in response to the rejection, while Daiichi Life’s attempt to secure control remains unsuccessful.